ADVANCED BILIARY TRACT CANCER
Clinical trials for ADVANCED BILIARY TRACT CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED BILIARY TRACT CANCER trials appear
Sign up with your email to follow new studies for ADVANCED BILIARY TRACT CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to extend life in advanced bile duct cancer
Disease control Recruiting nowThis study tests whether adding a new drug (SHR-8068) to standard immunotherapy and chemotherapy can help people with advanced bile duct cancer live longer. About 604 adults who have not had prior treatment will be randomly assigned to receive either the new combination or anothe…
Matched conditions: ADVANCED BILIARY TRACT CANCER
Phase: PHASE3 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 04:18 UTC
-
New hope for bile duct cancer: experimental drug enters final testing phase
Disease control Recruiting nowThis study tests a new drug called nanvuranlat in people with advanced biliary tract cancer (bile duct cancer) that has already been treated. About 480 adults will receive either nanvuranlat or standard treatments (chemotherapy or supportive care). The goal is to see if nanvuranl…
Matched conditions: ADVANCED BILIARY TRACT CANCER
Phase: PHASE3 • Sponsor: J-Pharma Co., Ltd. • Aim: Disease control
Last updated May 04, 2026 16:22 UTC